Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.10
Delayed Data
As of 4:00pm ET
 +0.05 / +4.76%
Today’s Change
0.67
Today|||52-Week Range
2.35
-9.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$162.7M

Company Description

Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing self-administered parenteral therapeutic products. It has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.

Contact Information

Antares Pharma, Inc.
100 Charles Ewing Boulevard
Ewing New Jersey 08628
P:(609) 359-3020
Investor Relations:
(609) 359-3016

Employees

Shareholders

Other institutional31.37%
Individual stakeholders20.86%
Mutual fund holders11.74%

Top Executives

Robert F. ApplePresident, Chief Executive Officer & Director
James E. FickenscherChief Financial Officer & Senior Vice President
Peter L. SadowskiChief Technology Officer
Peter J. GrahamSecretary, Chief Compliance Officer & Senior VP
Patrick MadsenSenior Vice President-Operations